Lifestyle Factors Tied to Canine Dementia Risk

A large scientific effort tracking how dogs grow old is generating findings that researchers say could help clarify the biology of aging and brain disease in humans.

The Dog Aging Project, launched in 2014, has enrolled more than 50,000 dogs and is using their faster life cycle to study conditions that often emerge with age, including cognitive decline that resembles human dementia.

What the project is doing

The initiative is run across multiple institutions and was co-founded by biologist Matt Kaeberlein. Scientists collect detailed information on diet and physical activity, draw blood, and perform brain MRI scans as part of the research program.

In addition to living-dog assessments, the project also examines donated canine brains after death. Those post-mortem studies are used to compare disease-related changes in dog tissue with patterns seen in human neurodegenerative disorders.

Key findings reported so far

Researchers have reported links between everyday factors and health outcomes in the canine cohort. One example highlighted by the project is that dogs living with other dogs were found to have fewer diseases.

Another reported association involves activity levels and cognitive health: dogs that did not get enough exercise showed a six-fold higher risk of developing dementia. The project frames these as correlations drawn from its dataset, not proof of cause and effect.

Why dog brains are drawing attention

Neuropathologist Dr. Dirk Keene has described finding beta-amyloid plaques in canine brain tissue examined through the project. Beta-amyloid plaques are widely recognized as a hallmark seen in human Alzheimer’s disease, and their presence in dogs is being used to explore biological overlap between species.

The project has also cited individual donated cases, including a dog named Spring, as part of its post-mortem work. These examinations have been described as showing pathological similarities to human dementia.

Data access and research output

The Dog Aging Project says its dataset is available for researchers around the world to use. The program reports that the data have supported more than 50 scientific studies to date.

That open-access approach matters for replication and for comparing results across labs, but important details are not provided in the available summary, including how studies define “insufficient exercise,” how dementia is diagnosed across breeds, and how confounding factors are handled.

Drug research: rapamycin as a test case

Alongside observational work, the project is investigating interventions that might affect aging. One focus is rapamycin, a drug that has been reported to raise life expectancy by 60% in mice and to slow cognitive decline in that species.

In pilot studies involving dogs with dementia, rapamycin has been described as potentially lowering microglial cells, which are linked to inflammation in the brain. The summary does not specify sample sizes, dosing, or clinical outcomes in dogs, leaving uncertainty about how broadly the early findings can be applied.